Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia; a Study on Behalf of the PDWP of the EBMT

In this retrospective study, scientists analyzed 66 patients with allo-hematopoietic stem cell transplantation, reported in the European Society for Blood and Marrow Transplantation registry. Bone marrow was the most widely used stem cell source followed by peripheral blood, and unrelated umbilical cord blood.